Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dietel

Showing results (21-30 of 277) with videos related to

Pageof 28
Sort By:
Der Pathologe|September 15, 2011
[Opening address of the president of the German Society of Pathology e.V]M Dietel
Cancer Detection and Prevention|January 1, 1983
Discrimination between benign, borderline, and malignant epithelial ovarian tumors using tumor markers: an immunohistochemical studyM Dietel
Pathology, Research and Practice|June 1, 1987
What's new in receptor mediated growth promotion of normal and malignant cells?M Dietel
Virchows Archiv : an International Journal of Pathology|July 6, 2000
Serous tumors of low malignant potential of the ovary. 1. Diagnostic pathologyM Dietel, S Hauptmann
Experimental and Clinical Endocrinology|January 1, 1993
Endocrine markers in malignant tumor cells producing parathyroid hormone-related proteinM Zabel, M Dietel
Gene|October 31, 1996
Cloning of a human cDNA encoding a protein with high homology to yeast methionyl-tRNA synthetaseH Lage, M Dietel
Histochemistry|January 1, 1987
S-100 protein and neuron-specific enolase in parathyroid glands and C-cells of the thyroidM Zabel, M Dietel
Histopathology|January 13, 2000
Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and BO Kaufmann, M Dietel
Virchows Archiv : an International Journal of Pathology|July 27, 2001
Serous tumors of low malignant potential of the ovary-molecular pathology: part 2S Hauptmann, M Dietel
The Lancet. Oncology|March 22, 2002
Effect of the breast-cancer resistance protein on atypical multidrug resistanceH Lage, M Dietel
Pageof 28

Showing results (21-30 of 277) with videos related to

Sort By:
Pageof 28
Der Pathologe|September 15, 2011
[Opening address of the president of the German Society of Pathology e.V]M Dietel
Cancer Detection and Prevention|January 1, 1983
Discrimination between benign, borderline, and malignant epithelial ovarian tumors using tumor markers: an immunohistochemical studyM Dietel
Pathology, Research and Practice|June 1, 1987
What's new in receptor mediated growth promotion of normal and malignant cells?M Dietel
Virchows Archiv : an International Journal of Pathology|July 6, 2000
Serous tumors of low malignant potential of the ovary. 1. Diagnostic pathologyM Dietel, S Hauptmann
Experimental and Clinical Endocrinology|January 1, 1993
Endocrine markers in malignant tumor cells producing parathyroid hormone-related proteinM Zabel, M Dietel
Gene|October 31, 1996
Cloning of a human cDNA encoding a protein with high homology to yeast methionyl-tRNA synthetaseH Lage, M Dietel
Histochemistry|January 1, 1987
S-100 protein and neuron-specific enolase in parathyroid glands and C-cells of the thyroidM Zabel, M Dietel
Histopathology|January 13, 2000
Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and BO Kaufmann, M Dietel
Virchows Archiv : an International Journal of Pathology|July 27, 2001
Serous tumors of low malignant potential of the ovary-molecular pathology: part 2S Hauptmann, M Dietel
The Lancet. Oncology|March 22, 2002
Effect of the breast-cancer resistance protein on atypical multidrug resistanceH Lage, M Dietel
Pageof 28